| | | | | |
| €11,1603 | +0,00% | €212,86M | €335,80K | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | €9,9833 | +0,00% | €212,78M | €139,92K | |
GTERA Globa Terra Acquisition Corporation Class A Ordinary Shares | €8,9893 | -0,10% | €212,66M | €4,11K | |
NUS NuSkin Enterprises, Inc. | €4,4903 | +2,59% | €212,50M | €658,53K | |
FHTX Foghorn Therapeutics Inc. Common Stock | €3,6097 | -0,24% | €212,44M | €112,20K | |
FATE Fate Therapeutics, Inc. | €1,8048 | -0,96% | €212,40M | €2,96M | |
| €11,1429 | +0,16% | €211,46M | €330,27K | |
VABK Virginia National Bankshares Corporation Common Stock | €38,3549 | -1,61% | €211,38M | €7,91K | |
SCM STELLUS CAPITAL INVESTMENT CORPORATION | €7,4460 | +2,28% | €210,74M | €199,61K | |
IKT Inhibikase Therapeutics, Inc. Common Stock | €1,5912 | -0,27% | €210,66M | €843,43K | |
ARL American Realty Investors, Inc. | €13,9504 | +0,00% | €209,97M | €2,76K | |
RAAQ Real Asset Acquisition Corp. Class A Ordinary Share | €9,1375 | +0,10% | €209,96M | €1,26M | |
MCGA Yorkville Acquisition Corp. Class A Ordinary Share | €8,9065 | -0,15% | €209,71M | €34,25K | |
DHY Credit Suisse High Yield Credit Fund | €1,5171 | +0,00% | €209,58M | €1,00M | |
SOCA Solarius Capital Acquisition Corp. Class A Ordinary Share | €8,9283 | -0,39% | €209,57M | €28,77 | |
